Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A
KNSA
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.89B
Close$
$84.67
11.3% upsideKiniksa Pharmaceuticals International Plc. Target Price Details
Target Price by Analysts
11.3% upsideKiniksa Pharmaceuticals International Plc. Target Price Details$-4.53
106% downside
Current Fair Value
106% downsideOvervalued by 106% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.89 Billion |
|---|---|
| Enterprise Value | $5.74 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.8 |
| Beta | 0.09 |
| Outstanding Shares | 77,577,675 |
Return
| Return on Equity | 12.33% |
|---|---|
| Return on Assets | 9.00% |
| Return on Invested Capital | 14.36% |
Valuation & Multiples
| P/E Ratio | 72.19 |
|---|---|
| PEG | 169.37 |
| Price to Sales | 7.61 |
| Price to Book Ratio | 9.51 |
| Enterprise Value to Revenue | 6.83 |
| Enterprise Value to EBIT | 55.14 |
| Enterprise Value to Net Income | 71 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$0.24
Average shareholder expectationRevenue Estimate
$226.33 M
Average shareholder expectationNext Earnings Call
Expected Date
October 27, 2026
EPS Estimate
$0.39
Average shareholder expectationRevenue Estimate
$259.65 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 3.5733▲ 355.13% |
|---|---|
| Total Calls | 90,700▼ 91.50% |
| Total Puts | 324,100▲ 1279.15% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 60.67%▲ 1.33% |
|---|---|
| Total Invested | $3.00B▲ 37.51% |
| Investors Holding | 276▲ 42.00% |
ESG Score
No data